Quercetin (Respiratory).

Bromelain is a proteolytic enzyme that thins mucus secretions and has been paired with quercetin in upper airway formulas for decades. It also improves the uptake of co-administered flavonoids from the gut.

Quercetin becomes an oxidised radical after quenching one, and ascorbate donates the electron that restores it. Ascorbate is also concentrated in airway lining fluid and in phagocytes.

Quercetin moves zinc ions across lipid membranes independently of zinc transporters, raising intracellular zinc. Intracellular zinc is what supports normal immune cell function.

NAC breaks disulfide bridges in mucus glycoproteins and supplies cysteine for glutathione synthesis. Quercetin works on mast cell membrane stability and redox signalling instead.

Both flavones stabilise the mast cell membrane and reduce degranulation and histamine release. Their potency profiles across mediator types differ, so the combination covers more of the response.

Apigenin is a closely related flavone acting on mast cell activation and NF-kB signalling. It works alongside quercetin on the same cell type through overlapping chemistry.

Nettle constituents act on histamine receptor signalling and mediator release in the nasal lining. Quercetin acts upstream at the mast cell membrane, and the two are long-standing formula partners for seasonal airway comfort.

Elderberry anthocyanins act on innate immune signalling. Quercetin adds mast cell stabilisation and redox support from the same polyphenol family.

Vitamin D receptor signalling drives antimicrobial peptide expression in airway epithelium. That is a distinct route from quercetin's action on mast cells and redox signalling.

Gut wall and liver UGT and SULT enzymes conjugate most ingested quercetin before it reaches circulation. Piperine inhibits those enzymes and P-glycoprotein efflux, so more of the flavonol arrives intact.

Quercetin dissolves poorly in intestinal fluid, which limits how much is ever available. Complexing it with phospholipids improves dispersion, which is the basis of phytosome forms.

The catechol ring of quercetin binds iron into a complex the enterocyte cannot take up. Non-heme iron absorption drops when the two share a serving, so they are spaced apart.

Quercetin inhibits catechol-O-methyltransferase and efflux transporters that clear EGCG, so EGCG exposure rises when both are taken. Both also act on overlapping redox and NF-kB signalling.

Rutin is quercetin carrying a rutinose sugar, and human enzymes do not remove that disaccharide in the small intestine, so colonic microbiota release the aglycone further down. This is why rutin and quercetin dihydrate give different absorption timing and different plasma peaks. Taking both spreads exposure rather than doubling it, and rutin is by far the most co-studied partner in the literature index for quercetin.

Flavonols bind iron avidly and non-heme iron absorption falls when polyphenols are present in the same meal. Anyone taking quercetin for airway comfort and iron for iron status should separate the two by a couple of hours. The literature index also flags this co-occurrence as antagonistic, which matches the chemistry rather than contradicting it.

Quercetin chelates copper, and in cell-free systems the quercetin copper complex can generate rather than quench reactive species. That behaviour is a laboratory observation and has not been shown to matter at supplement intakes in people. It is still a reason not to assume more of both is better.

When quercetin donates electrons it becomes a semiquinone and then a quinone, and glutathione conjugation is the route that keeps that reactive intermediate from binding cellular thiols. Glutathione status therefore sits behind quercetin's antioxidant handling rather than adding to it. Glutathione is also the single most co-studied partner in the index for this ingredient.

Glutathione peroxidase needs a selenocysteine residue to reduce peroxides, so the enzyme arm that a flavonol feeds into depends on selenium status. Selenium adds nothing directly to flavonol chemistry. It keeps the downstream enzyme working normally.

Alpha-tocopherol works inside the membrane while quercetin partitions at the membrane surface and in the aqueous phase, and flavonols can regenerate the tocopheroxyl radical in model systems. The two therefore cover different compartments. Compartment coverage is a mechanistic claim, not a measured clinical effect.

Dihydrolipoate regenerates several redox partners and supports intracellular glutathione supply, which is the same pool that conjugates the quercetin quinone. Pairing them stacks the recycling side of the network rather than adding a second radical scavenger. No combination trial in respiratory or airway settings is cited here.

Ubiquinol is the membrane-resident reductant that keeps tocopherol in its active form, sitting one step from where quercetin acts at the membrane surface. The pairing is a network argument drawn from established biochemistry. It has not been tested as a combination for airway comfort in the sources listed here.

Both compounds are cleared mainly as glucuronides and sulfates, so taken together they compete for the same UGT and SULT capacity and each can raise the other's free fraction. Resveratrol appears as one of the most frequent quercetin co-study partners in the literature index. Regard the pairing as a pharmacokinetic interaction first and an additive effect second.

Curcuminoids and quercetin are both extensively glucuronidated in the gut wall and liver, and both are frequently formulated with absorption aids for that reason. Combining them can change the exposure of either. Curcumin is among the top co-studied partners for quercetin in the index.

Fermentable oligosaccharides shift colonic bacterial composition, and colonic bacteria are what free the aglycone from quercetin glycosides. The link from prebiotic to measurable quercetin exposure has not been demonstrated in the sources here. A review in this candidate set does place polyphenols, the gut microbiota and inflammasome signalling on one axis.

Quercetin aglycone is close to insoluble in water, and dispersing it in a medium-chain triglyceride or taking it with fat improves how much reaches the enterocyte. This is formulation physics rather than a biological synergy, and no combination trial for airway comfort is cited here.

Several flavonoids including quercetin inhibit thyroid peroxidase in vitro, the enzyme that incorporates iodine into thyroglobulin. Whether ordinary supplemental intakes do this in people has not been established. It is worth flagging for anyone taking high flavonol doses alongside iodine, and it is a caution rather than a finding.